+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antivenoms Market - Global Forecast 2025-2030- Product Image
Antivenoms Market - Global Forecast 2025-2030- Product Image
Sale

Antivenoms Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888550
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antivenoms market is evolving rapidly amid global health challenges, heightened regulatory scrutiny, and the ongoing need for innovative solutions that ensure patient safety and supply chain resilience. Senior leaders are navigating a complex landscape shaped by scientific, operational, and policy shifts impacting the availability and efficacy of antivenom therapies.

Market Snapshot: Antivenoms Market Size and Growth

The Antivenoms Market grew from USD 2.87 billion in 2024 to USD 3.09 billion in 2025. It is expected to continue growing at a CAGR of 7.27%, reaching USD 4.38 billion by 2030. This expansion is fueled by rising global envenomation incidents, advances in immunology and purification, and greater awareness among healthcare systems. Diversified product portfolios and expanding regional manufacturing contribute to a more robust market ecosystem, enabling improved outcomes and supply reliability.

Scope & Segmentation

  • Administration Route: Intramuscular, Intravenous
  • Application: Human (Adult, Pediatric), Veterinary (Companion Animals, Livestock)
  • Host Animal: Caprine, Equine, Ovine
  • Therapeutic Area: Scorpion Envenomation, Snake Envenomation, Spider Envenomation
  • Dosage Form: Liquid, Lyophilized
  • End User: Outpatient Clinics, Specialty Clinics, Private Hospitals, Public Hospitals, Research Institutes
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy (Direct To Consumer, Third Party Platform), Retail Pharmacy
  • Product Type: F(ab')2, Fab, IgG
  • Regions Covered: Americas (including the United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Companies Profiled: Sanofi S.A., CSL Limited, Instituto Butantan, VINS Bioproducts Limited, Premium Serums & Vaccines Private Limited, MicroPharm Limited, Instituto Clodomiro Picado, Rare Disease Therapeutics Limited, Bharat Serums and Vaccines Limited, Haffkine Biopharmaceutical Corporation Limited

Key Takeaways for Senior Decision-Makers

  • Innovation in recombinant antibody engineering is reshaping antivenom development, improving safety profiles, and broadening therapeutic applications for diverse envenomation scenarios.
  • Regulatory harmonization in major and emerging markets is streamlining approval pathways and facilitating better lifecycle management for new and existing antivenom therapies.
  • Market access strategies increasingly leverage digital distribution platforms and inventory tracing, enhancing responsiveness to remote and high-incidence regions.
  • Public-private partnerships and evolving financial models help address affordability challenges in low-resource settings, strengthening the case for equitable access.
  • Segment-specific solutions such as lyophilized forms and tailored dosing support differentiated strategies for rural, pediatric, veterinary, and field-based care applications.
  • Collaborations between manufacturers, academic centers, and health agencies are driving faster innovation and the adoption of unified quality, safety, and monitoring standards.

Tariff Impact: Navigating New US Trade Dynamics

Recent tariff implementations in the United States are driving up costs for imported immunoglobulin raw materials and finished products. This is compelling manufacturers to re-evaluate sourcing, adopt tighter inventory controls, and optimize supply chain configurations. Smaller producers are exploring local alternatives and volume-based concessions, while larger companies leverage diverse sourcing and in-house extraction. The industry focus is shifting toward resilient, transparent operations in response to geopolitical and trade uncertainties.

Methodology & Data Sources

This analysis is grounded in primary interviews with senior executives, R&D specialists, and regulatory experts from leading antivenom producers and health agencies. Comprehensive secondary research draws on scientific literature, clinical trial data, policy documents, and official company disclosures. Data consistency was achieved through triangulation and peer-reviewed validation, ensuring robust market insight.

Why This Report Matters

  • Equips decision-makers with actionable intelligence for navigating regulatory, technological, and trade-driven market dynamics.
  • Provides comprehensive segmentation to help optimize product strategies, portfolio management, and regional market prioritization.
  • Enables proactive risk management by highlighting emerging threats, evolving requirements, and best practices for operational resilience and growth.

Conclusion

The antivenoms market is undergoing transformation through scientific, operational, and policy innovation. Strategic focus on partnerships, agile manufacturing, and supply chain diversification will be essential for sustaining growth and expanding access in a complex global environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of recombinant monoclonal antibody antivenoms reducing adverse reaction rates
5.2. Growing public-private partnerships to scale local antivenom production in sub-Saharan Africa
5.3. Adoption of omics-based venom profiling to design region-specific polyvalent antivenoms
5.4. Implementation of cold-chain optimization solutions to improve antivenom accessibility in rural areas
5.5. Integration of AI-driven venom toxin mapping to accelerate antivenom discovery pipelines
5.6. Rising demand for lyophilized antivenom formulations enhancing stability in hot climates
5.7. Regulatory incentives accelerating clinical trials for next-generation synthetic antivenoms
5.8. Development of smartphone-enabled snakebite management platforms linking patients to antivenom suppliers
5.9. Emergence of synthetic peptide-based antivenom candidates reducing reliance on equine immunization
5.10. Shift towards decentralized antivenom distribution networks enabled by drone delivery pilots in remote regions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antivenoms Market, by Administration Route
8.1. Introduction
8.2. Intramuscular
8.3. Intravenous
9. Antivenoms Market, by Application
9.1. Introduction
9.2. Human
9.2.1. Adult
9.2.2. Pediatric
9.3. Veterinary
9.3.1. Companion Animals
9.3.2. Livestock
10. Antivenoms Market, by Host Animal
10.1. Introduction
10.2. Caprine
10.3. Equine
10.4. Ovine
11. Antivenoms Market, by Therapeutic Area
11.1. Introduction
11.2. Scorpion Envenomation
11.3. Snake Envenomation
11.4. Spider Envenomation
12. Antivenoms Market, by Dosage Form
12.1. Introduction
12.2. Liquid
12.3. Lyophilized
13. Antivenoms Market, by End User
13.1. Introduction
13.2. Clinics
13.2.1. Outpatient Clinics
13.2.2. Specialty Clinics
13.3. Hospitals
13.3.1. Private Hospitals
13.3.2. Public Hospitals
13.4. Research Institutes
14. Antivenoms Market, by Distribution Channel
14.1. Introduction
14.2. Hospital Pharmacy
14.3. Online Pharmacy
14.3.1. Direct To Consumer
14.3.2. Third Party Platform
14.4. Retail Pharmacy
15. Antivenoms Market, by Product Type
15.1. Introduction
15.2. F(ab')2
15.3. Fab
15.4. IgG
16. Americas Antivenoms Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Antivenoms Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Antivenoms Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Sanofi S.A.
19.3.2. CSL Limited
19.3.3. Instituto Butantan
19.3.4. VINS Bioproducts Limited
19.3.5. Premium Serums & Vaccines Private Limited
19.3.6. MicroPharm Limited
19.3.7. Instituto Clodomiro Picado
19.3.8. Rare Disease Therapeutics Limited
19.3.9. Bharat Serums and Vaccines Limited
19.3.10. Haffkine Biopharmaceutical Corporation Limited
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. ANTIVENOMS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIVENOMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIVENOMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIVENOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIVENOMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIVENOMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTIVENOMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTIVENOMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ANTIVENOMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. ANTIVENOMS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 31. ANTIVENOMS MARKET: RESEARCHAI
FIGURE 32. ANTIVENOMS MARKET: RESEARCHSTATISTICS
FIGURE 33. ANTIVENOMS MARKET: RESEARCHCONTACTS
FIGURE 34. ANTIVENOMS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTIVENOMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIVENOMS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIVENOMS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIVENOMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIVENOMS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIVENOMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIVENOMS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIVENOMS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIVENOMS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIVENOMS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIVENOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIVENOMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIVENOMS MARKET SIZE, BY HUMAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIVENOMS MARKET SIZE, BY HUMAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIVENOMS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIVENOMS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIVENOMS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIVENOMS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIVENOMS MARKET SIZE, BY HUMAN, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIVENOMS MARKET SIZE, BY HUMAN, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIVENOMS MARKET SIZE, BY VETERINARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIVENOMS MARKET SIZE, BY VETERINARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIVENOMS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIVENOMS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIVENOMS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIVENOMS MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIVENOMS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIVENOMS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIVENOMS MARKET SIZE, BY CAPRINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIVENOMS MARKET SIZE, BY CAPRINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIVENOMS MARKET SIZE, BY EQUINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIVENOMS MARKET SIZE, BY EQUINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIVENOMS MARKET SIZE, BY OVINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIVENOMS MARKET SIZE, BY OVINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIVENOMS MARKET SIZE, BY SCORPION ENVENOMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIVENOMS MARKET SIZE, BY SCORPION ENVENOMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIVENOMS MARKET SIZE, BY SNAKE ENVENOMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIVENOMS MARKET SIZE, BY SNAKE ENVENOMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIVENOMS MARKET SIZE, BY SPIDER ENVENOMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIVENOMS MARKET SIZE, BY SPIDER ENVENOMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIVENOMS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTIVENOMS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIVENOMS MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTIVENOMS MARKET SIZE, BY LYOPHILIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIVENOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTIVENOMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTIVENOMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTIVENOMS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTIVENOMS MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTIVENOMS MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTIVENOMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTIVENOMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTIVENOMS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTIVENOMS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTIVENOMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTIVENOMS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTIVENOMS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTIVENOMS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANTIVENOMS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANTIVENOMS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANTIVENOMS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANTIVENOMS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ANTIVENOMS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ANTIVENOMS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ANTIVENOMS MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ANTIVENOMS MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ANTIVENOMS MARKET SIZE, BY THIRD PARTY PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ANTIVENOMS MARKET SIZE, BY THIRD PARTY PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ANTIVENOMS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ANTIVENOMS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ANTIVENOMS MARKET SIZE, BY F(AB')2, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ANTIVENOMS MARKET SIZE, BY F(AB')2, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ANTIVENOMS MARKET SIZE, BY FAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ANTIVENOMS MARKET SIZE, BY FAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ANTIVENOMS MARKET SIZE, BY IGG, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ANTIVENOMS MARKET SIZE, BY IGG, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ANTIVENOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ANTIVENOMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ANTIVENOMS MARKET SIZE, BY HUMAN, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ANTIVENOMS MARKET SIZE, BY HUMAN, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ANTIVENOMS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ANTIVENOMS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ANTIVENOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ANTIVENOMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ANTIVENOMS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ANTIVENOMS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ANTIVENOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ANTIVENOMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ANTIVENOMS MARKET SIZE, BY HUMAN, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ANTIVENOMS MARKET SIZE, BY HUMAN, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ANTIVENOMS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ANTIVENOMS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES ANTIVENOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES ANTIVENOMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES ANTIVENOMS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES ANTIVENOMS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 153. CANADA ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 154. CANADA ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 155. CANADA ANTIVENOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA ANTIVENOMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA ANTIVENOMS MARKET SIZE, BY HUMAN, 2018-2024 (USD MILLION)
TABLE 158. CANADA ANTIVENOMS MARKET SIZE, BY HUMAN, 2025-2030 (USD MILLION)
TABLE 159. CANADA ANTIVENOMS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 160. CANADA ANTIVENOMS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 161. CANADA ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2018-2024 (USD MILLION)
TABLE 162. CANADA ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2025-2030 (USD MILLION)
TABLE 163. CANADA ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 164. CANADA ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 165. CANADA ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 166. CANADA ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 167. CANADA ANTIVENOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. CANADA ANTIVENOMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. CANADA ANTIVENOMS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 170. CANADA ANTIVENOMS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 171. CANADA ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 172. CANADA ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 173. CANADA ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. CANADA ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. CANADA ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 176. CANADA ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 177. CANADA ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. CANADA ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 180. MEXICO ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 181. MEXICO ANTIVENOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. MEXICO ANTIVENOMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. MEXICO ANTIVENOMS MARKET SIZE, BY HUMAN, 2018-2024 (USD MILLION)
TABLE 184. MEXICO ANTIVENOMS MARKET SIZE, BY HUMAN, 2025-2030 (USD MILLION)
TABLE 185. MEXICO ANTIVENOMS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO ANTIVENOMS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2018-2024 (USD MILLION)
TABLE 188. MEXICO ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2025-2030 (USD MILLION)
TABLE 189. MEXICO ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 190. MEXICO ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 191. MEXICO ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 192. MEXICO ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 193. MEXICO ANTIVENOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. MEXICO ANTIVENOMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. MEXICO ANTIVENOMS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO ANTIVENOMS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. MEXICO ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. MEXICO ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 202. MEXICO ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 203. MEXICO ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. MEXICO ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL ANTIVENOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL ANTIVENOMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL ANTIVENOMS MARKET SIZE, BY HUMAN, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL ANTIVENOMS MARKET SIZE, BY HUMAN, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL ANTIVENOMS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL ANTIVENOMS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL ANTIVENOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL ANTIVENOMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL ANTIVENOMS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL ANTIVENOMS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA ANTIVENOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA ANTIVENOMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA ANTIVENOMS MARKET SIZE, BY HUMAN, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA ANTIVENOMS MARKET SIZE, BY HUMAN, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA ANTIVENOMS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA ANTIVENOMS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA ANTIVENOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA ANTIVENOMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA ANTIVENOMS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA ANTIVENOMS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY HUMAN, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY HUMAN, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY HUMAN, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY HUMAN, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. GERMANY ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 312. GERMANY ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 313. GERMANY ANTIVENOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. GERMANY ANTIVENOMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. GERMANY ANTIVENOMS MARKET SIZE, BY HUMAN, 2018-2024 (USD MILLION)
TABLE 316. GERMANY ANTIVENOMS MARKET SIZE, BY HUMAN, 2025-2030 (USD MILLION)
TABLE 317. GERMANY ANTIVENOMS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 318. GERMANY ANTIVENOMS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 319. GERMANY ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2018-2024 (USD MILLION)
TABLE 320. GERMANY ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2025-2030 (USD MILLION)
TABLE 321. GERMANY ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 322. GERMANY ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 323. GERMANY ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 324. GERMANY ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 325. GERMANY ANTIVENOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. GERMANY ANTIVENOMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. GERMANY ANTIVENOMS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 328. GERMANY ANTIVENOMS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 329. GERMANY ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 330. GERMANY ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 331. GERMANY ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. GERMANY ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. GERMANY ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 334. GERMANY ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 335. GERMANY ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 336. GERMANY ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 337. FRANCE ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 338. FRANCE ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 339. FRANCE ANTIVENOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 340. FRANCE ANTIVENOMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 341. FRANCE ANTIVENOMS MARKET SIZE, BY HUMAN, 2018-2024 (USD MILLION)
TABLE 342. FRANCE ANTIVENOMS MARKET SIZE, BY HUMAN, 2025-2030 (USD MILLION)
TABLE 343. FRANCE ANTIVENOMS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 344. FRANCE ANTIVENOMS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 345. FRANCE ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2018-2024 (USD MILLION)
TABLE 346. FRANCE ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2025-2030 (USD MILLION)
TABLE 347. FRANCE ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 348. FRANCE ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 349. FRANCE ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 350. FRANCE ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 351. FRANCE ANTIVENOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. FRANCE ANTIVENOMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 353. FRANCE ANTIVENOMS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 354. FRANCE ANTIVENOMS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 355. FRANCE ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 356. FRANCE ANTIVENOMS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 357. FRANCE ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 358. FRANCE ANTIVENOMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 359. FRANCE ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 360. FRANCE ANTIVENOMS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 361. FRANCE ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 362. FRANCE ANTIVENOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 363. RUSSIA ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 364. RUSSIA ANTIVENOMS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 365. RUSSIA ANTIVENOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 366. RUSSIA ANTIVENOMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 367. RUSSIA ANTIVENOMS MARKET SIZE, BY HUMAN, 2018-2024 (USD MILLION)
TABLE 368. RUSSIA ANTIVENOMS MARKET SIZE, BY HUMAN, 2025-2030 (USD MILLION)
TABLE 369. RUSSIA ANTIVENOMS MARKET SIZE, BY VETERINARY, 2018-2024 (USD MILLION)
TABLE 370. RUSSIA ANTIVENOMS MARKET SIZE, BY VETERINARY, 2025-2030 (USD MILLION)
TABLE 371. RUSSIA ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2018-2024 (USD MILLION)
TABLE 372. RUSSIA ANTIVENOMS MARKET SIZE, BY HOST ANIMAL, 2025-2030 (USD MILLION)
TABLE 373. RUSSIA ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 374. RUSSIA ANTIVENOMS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 375. RUSSIA ANTIVENOMS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 376. RUSSIA ANTIVENOMS MARKET SIZE, BY DOSAGE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antivenoms market report include:
  • Sanofi S.A.
  • CSL Limited
  • Instituto Butantan
  • VINS Bioproducts Limited
  • Premium Serums & Vaccines Private Limited
  • MicroPharm Limited
  • Instituto Clodomiro Picado
  • Rare Disease Therapeutics Limited
  • Bharat Serums and Vaccines Limited
  • Haffkine Biopharmaceutical Corporation Limited

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.09 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.38 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Antivenom: Market Share, and Growth Analysis by Product Type (Monovalent Antivenom, Polyvalent Antivenom), Application, End User, Technology - Product Image

Antivenom: Market Share, and Growth Analysis by Product Type (Monovalent Antivenom, Polyvalent Antivenom), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Antivenom Market Report 2025 - Product Image

Antivenom Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Anti-venom Market Size, Share, Trends and Forecast by Species, Anti-Venom Type, Mode of Action, End User, and Region, 2025-2033 - Product Image

Anti-venom Market Size, Share, Trends and Forecast by Species, Anti-Venom Type, Mode of Action, End User, and Region, 2025-2033

  • Report
  • 145 Pages
  • Global
From
Anti-venom Market 2024-2028 - Product Image

Anti-venom Market 2024-2028

  • Report
  • 159 Pages
  • Global
From
Anti Venoms - Global Strategic Business Report - Product Image

Anti Venoms - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.